News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
735,727 Results
Type
Article (63545)
Company Profile (328)
Press Release (671854)
Section
Business (212272)
Career Advice (2361)
Deals (36263)
Drug Delivery (89)
Drug Development (84262)
Employer Resources (174)
FDA (16503)
Job Trends (15484)
News (358466)
Policy (33824)
Tag
Academia (2897)
Alliances (52438)
Alzheimer's disease (1292)
Approvals (16419)
Artificial intelligence (128)
Bankruptcy (358)
Best Places to Work (11828)
Biotechnology (224)
Breast cancer (113)
Cancer (1002)
Cardiovascular disease (85)
Career advice (1967)
Cell therapy (223)
Clinical research (66161)
Collaboration (354)
Compensation (173)
COVID-19 (2710)
C-suite (93)
Data (952)
Diabetes (144)
Diagnostics (6402)
Earnings (85636)
Employer resources (153)
Events (113526)
Executive appointments (262)
FDA (16977)
Funding (316)
Gene therapy (163)
GLP-1 (603)
Government (4544)
Healthcare (19454)
Infectious disease (2791)
Inflammatory bowel disease (105)
Interviews (401)
IPO (16556)
Job creations (3986)
Job search strategy (1683)
Layoffs (434)
Legal (8134)
Lung cancer (163)
Manufacturing (168)
Medical device (13442)
Medtech (13447)
Mergers & acquisitions (19739)
Metabolic disorders (392)
Neuroscience (1553)
NextGen Class of 2024 (6818)
Non-profit (4829)
Northern California (1321)
Obesity (232)
Opinion (197)
Patents (96)
People (58938)
Phase I (20592)
Phase II (29013)
Phase III (21576)
Pipeline (325)
Postmarket research (2925)
Preclinical (9300)
Radiopharmaceuticals (246)
Rare diseases (197)
Real estate (6453)
Regulatory (22391)
Research institute (2612)
Resumes & cover letters (392)
Southern California (1182)
Startups (3814)
United States (12576)
Vaccines (588)
Weight loss (175)
Date
Last 7 days (1083)
Last 30 days (3201)
Last 365 days (36303)
2024 (32014)
2023 (41105)
2022 (52384)
2021 (57025)
2020 (55709)
2019 (48522)
2018 (36607)
2017 (33843)
2016 (33881)
2015 (40476)
2014 (34377)
2013 (30567)
2012 (32171)
2011 (32528)
2010 (31142)
Location
Africa (876)
Arizona (202)
Asia (40820)
Australia (7134)
California (2991)
Canada (1213)
China (228)
Colorado (128)
Connecticut (135)
Europe (91601)
Florida (417)
Georgia (107)
Illinois (339)
Indiana (190)
Kansas (99)
Maryland (561)
Massachusetts (2413)
Michigan (146)
Minnesota (266)
New Jersey (882)
New York (889)
North Carolina (723)
Northern California (1321)
Ohio (132)
Pennsylvania (786)
South America (1240)
Southern California (1182)
Texas (416)
Utah (87)
Washington State (344)
735,727 Results for "albany molecular research inc amri".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Cayman Chemical Expands Molecular Diagnostic Research Offerings Through Partnership with PCRassays.com
Cayman Chemical, a leading supplier of research tools for the life science community, has widened their portfolio to include molecular-based detection kits through a strategic partnership with PCRassays.com.
June 6, 2024
·
2 min read
Press Releases
Virscio Extends Translational Expertise and Research Services to Molecular Biology
October 22, 2024
·
1 min read
Lone Star Bio
Molecular Templates, Inc. Provides Interim Update
Molecular Templates, Inc. today provided an update on its clinical-stage programs.
June 3, 2024
·
7 min read
Earnings
Biogen Tops Wall Street Expectations for Leqembi, Inks Molecular Glue Deal
Biogen touted strong Q3 sales of its Alzheimer’s drug Leqembi a day after announcing a deal worth up to $1.45 billion with Neomorph to discover and develop molecular glue degraders.
October 30, 2024
·
2 min read
·
Heather McKenzie
Collaboration
Novartis Inks Potential $2.2B Molecular Glue Deal With Monte Rosa
The Swiss pharma is paying $150 million upfront to gain rights to Monte Rosa’s VAV1-targeting molecular glue degraders, led by a Phase I candidate which holds therapeutic promise for immune-mediated diseases.
October 28, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Biogen and Neomorph Announce Multi-Target Research Collaboration to Discover and Develop Molecular Glue Degraders for Alzheimer’s, Rare, and Immunological Diseases
October 29, 2024
·
5 min read
Business
Molecular Templates, Inc. Reports First Quarter 2024 Financial Results and Corporate Update
Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage biopharmaceutical company focused on the discovery and development of proprietary targeted biologic therapeutics, engineered toxin bodies (“ETBs”), to create novel therapies with potent differentiated mechanisms of action, today reported financial results and business updates for the first quarter of 2024.
May 15, 2024
·
6 min read
Business
Io Therapeutics, Inc., presented data from studies of IRX4204, the company’s phase II clinical stage RXR agonist for treatment of normal aging-related neurodegeneration, at the FASEB Science Research Conference on Cellular and Molecular Mechanisms of Brain Aging
September 18, 2024
·
3 min read
Press Releases
Rosalind Franklin University Scientist Awarded Research Grant to Study Molecular Mechanisms Driving Metastatic Breast Cancer
October 16, 2024
·
1 min read
Drug Development
Molecular Templates, Inc. Provides Interim Update
Molecular Templates, Inc. today provided an update on its programs.
March 4, 2024
·
9 min read
1 of 73,573
Next
